|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Myrcludex B>> Market Analysis Reports |
Market Analysis Reports of Myrcludex B |
|
Hepatitis D - Market Insights, Epidemiology and Market Forecast-2028 ... interferon lambda 1a (Eiger Biopharmaceuticals Inc.), Myrcludex B (MYR Pharma), Lonafarnib (Eiger Bio ... Hepatitis D - Pipeline Review, H1 2020 Hepatitis D - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H1 2020, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape. ... Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease, which ... Hepatitis D - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030 ... commentary Roche, Eiger Biopharmaceuticals Inc., Myrcludex B (Myr Pharma), Replicor Inc. Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021 ... -73763989 Selgantolimod REP 2139-Mg Antroquinonol Myrcludex B P1101 CKD-390 GC1102 ALG ... |